User:Shawndouglas/sandbox/sublevel4

While testing for SARS-CoV-2, the virus that causes COVID-19, is technically a part of clinical diagnostics, it integrates aspects of other lab types, such as clinical pathology and molecular diagnostics. As such, it shouldn’t be surprising that an effective clinical diagnostics LIMS built for COVID-19 testing should include a few unique features outside of a generic clinical LIMS solution. This becomes even more obvious when you consider the mandatory reporting requirements, specialist workflows, and demanding turn-around time (TAT) and accuracy requirements of testing patients for COVID-19.

In addition to the essential features of a standard LIMS, the COVID-19 lab will also be looking for a system that can (or allows users to):

• Conduct the specialty functions found in a clinical pathology LIMS.
• Conduct the specialty functions found in a molecular diagnostics and cytogenetics LIMS.
• Provide a flexible provider portal that includes disease-specific checks for test necessity.
• Support a wide variety of user, provider and patient data.
• Provide a clear preregistration module that can capture critical patient and facility information, as well as national reporting questions.
• Support queue-based specimen tracking.
• Provide default assays and workflows for SARS-CoV-2 testing.
• Set up custom workflows for unique SARS-CoV-2 testing.
• Set up automatic reflex testing.
• Interface with most popular complex and point-of-care instruments used in COVID-19 testing.
• Integrate with mandatory results reporting systems and EHRs.
• Ensure efficient, native report delivery via email, fax or provider portal.
• Provide a customizable dashboard that can display disease-specific data and information.